Dr Josef
@taperclinic·234K subscribers·1.7K videos
New Antipsychotic Combenfy: Marketing or Medical Breakthrough?
Posted
March 12, 2026
Views
1,513
Likes
67
Comments
3
Engagement
4.63%
March 12, 2026
1,513
67
3
4.63%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:12Now PlayingJournals discuss antipsychotic side effects not due to honesty, but a marketing campaign for a new drug, Combenfy. Developed by Professor Marta, it targets muscarinic receptors and costs $2,000/month. Marta profits as a paid consultant for psychiatric companies. #PharmaMarketing #Antipsychotics #DrugDevelopment #Psychiatry #Combenfy
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
